These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35107432)

  • 1. Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning.
    Pičulin M; Smole T; Žunkovič B; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier LS; Velicki L; Olivotto I; MacGowan GA; Jakovljević DG; Filipović N; Bosnić Z
    JMIR Med Inform; 2022 Feb; 10(2):e30483. PubMed ID: 35107432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
    Smole T; Žunkovič B; Pičulin M; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier L; Velicki L; MacGowan GA; Olivotto I; Filipović N; Jakovljević DG; Bosnić Z
    Comput Biol Med; 2021 Aug; 135():104648. PubMed ID: 34280775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
    Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Kochav SM; Raita Y; Fifer MA; Takayama H; Ginns J; Maurer MS; Reilly MP; Hasegawa K; Shimada YJ
    Int J Cardiol; 2021 Mar; 327():117-124. PubMed ID: 33181159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
    O'Mahony C; Jichi F; Pavlou M; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
    Eur Heart J; 2014 Aug; 35(30):2010-20. PubMed ID: 24126876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning modeling identifies hypertrophic cardiomyopathy subtypes with genetic signature.
    Dai J; Wang T; Xu K; Sun Y; Li Z; Chen P; Wang H; Wu D; Chen Y; Xiao L; Liu H; Wei H; Li R; Peng L; Yu T; Wang Y; Sun Z; Wang DW
    Front Med; 2023 Aug; 17(4):768-780. PubMed ID: 37121957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
    Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
    Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using Diagnostic Codes.
    Farahani NZ; Arunachalam SP; Sundaram DSB; Pasupathy K; Enayati M; Arruda-Olson AM
    Proceedings (IEEE Int Conf Bioinformatics Biomed); 2020 Dec; 2020():1932-1937. PubMed ID: 34316386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
    Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
    Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
    D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
    Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy.
    Bhopalwala H; Dewaswala N; Liu S; Scott CG; Welper JM; Akinnusotu O; Bos JM; Ommen SR; Ackerman MJ; Pellikka PA; Geske JB; Noseworthy P; Arruda-Olson AM
    Echocardiography; 2021 Feb; 38(2):183-188. PubMed ID: 33325582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).
    Bhattacharya M; Lu DY; Kudchadkar SM; Greenland GV; Lingamaneni P; Corona-Villalobos CP; Guan Y; Marine JE; Olgin JE; Zimmerman S; Abraham TP; Shatkay H; Abraham MR
    Am J Cardiol; 2019 May; 123(10):1681-1689. PubMed ID: 30952382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy.
    Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G
    Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.